SCHEMBL1922816

SCHEMBL1922816

CCOCCOCCn1nc(N2CCC(Oc3ccccc3C(F)(F)F)CC2)c(=O)n(C)c1=O.Cn1c(=O)c(N2CCC(Oc3ccccc3C(F)(F)F)CC2)nn(C2CCCCC2=O)c1=O

nearest known ligand 0.46

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ SCD O00767 15/20 0.46
▸ RBP4 P02753 1/20 0.36
▸ TTR P02766 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1781076 0.90 SCD (0.55) SCDRBP4TTR
SCHEMBL1781816 0.89 SCD (0.57) SCDRBP4TTR
SCHEMBL1783249 0.89 SCD (0.57) SCDRBP4TTR
SCHEMBL1781011 0.79 SCD (0.59) SCDRBP4TTR
SCHEMBL1922974 0.79 SCD (0.46) SCDRBP4TTR
SCHEMBL1783032 0.78 SCD (0.60) SCDRBP4TTR
SCHEMBL1784370 0.76 SCD (0.58) SCDRBP4TTR
SCHEMBL1782121 0.75 SCD (0.54) SCDRBP4TTR
SCHEMBL1779895 0.75 SCD (0.67) SCDRBP4TTR
SCHEMBL1783283 0.74 SCD (0.55) SCDRBP4TTR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2328886-A1 DERIVATIVES OF TRIAZINES AND URACILS, THEIR PREPARATION AND THEIR APPLICATION IN HUMAN THERAPEUTICS Pierre Fabre Médicament (FR) 2011-06-08 — — EP disclosed
WO-2010006962-A1 DERIVATIVES OF TRIAZINES AND URACILS, THEIR PREPARATION AND THEIR APPLICATION IN HUMAN THERAPEUTICS PIERRE FABRE MEDICAMENT (FR) 2010-01-21 — — WO disclosed
Send feedback